Pacira Pharmaceuticals Inc (PCRX)

Number of days of payables

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Payables turnover 11.76 12.05 8.67 12.30 13.09 13.64 11.47 9.77 13.30 17.30 10.83 13.06 11.25 8.76 11.60 6.89 8.34 6.15 7.16 6.83
Number of days of payables days 31.03 30.30 42.11 29.68 27.87 26.76 31.83 37.37 27.44 21.10 33.71 27.96 32.45 41.67 31.47 53.01 43.78 59.35 50.99 53.47

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 11.76
= 31.03

To analyze Pacira BioSciences Inc's number of days of payables, we look at the trend over the past eight quarters. The number of days of payables measures how long, on average, the company takes to pay its suppliers or vendors for goods or services purchased on credit.

The number of days of payables has fluctuated over the quarters, ranging from a low of 26.76 days in Q3 2022 to a high of 42.11 days in Q2 2023. Generally, a lower number of days of payables indicates the company is paying its suppliers more quickly, while a higher number suggests a longer payment period.

In Q4 2023, the number of days of payables was 31.03 days, increasing slightly from the previous quarter but remaining within a reasonable range compared to historical data. This could imply that Pacira BioSciences Inc is maintaining stable payment terms with its suppliers.

Overall, the trend in the number of days of payables for Pacira BioSciences Inc shows some variability but generally staying within manageable levels. Monitoring this ratio over time can provide insights into the company's liquidity management and relationships with its suppliers.